ADIPOQ and systemic sclerosis: In view of the emerging importance of adiponectin in modulating a broad range of cellular activities implicated in SSc pathogenesis, we sought to investigate the impact of AdipoRon, the first orally-active AdipoR agonist, in a preclinical model of SSc.